News, Policy & Media

24May

Government response to report on Brexit and medicines, medical devices and substances of human origin

Command paper responding to the Health and Social Care Committee's report 'Brexit: medicines, medical devices and substances of human origin'.

Published 23 May 2018
From:
Department of Health and Social Care, Intellectual Property Office, Medicines and Healthcare products Regulatory Agency, Office for Life Sciences, and Department for Exiting the European Union
Documents

Brexit: medicines, medical devices and substances of human origin – government response to the Health and Social Care Committee's 4th report of session 2017 to 2019
 

Details
This command paper sets out the government’s response to the Health and Social Care Committee’s report following their inquiry into Brexit: medicines, medical devices and substances of human origin.

The committee published their report on 21 March 2018.

This response was prepared by the Department of Health and Social Care, in collaboration with other government departments and agencies including:

the Medicines and Healthcare products Regulatory Agency
the Office for Life Sciences
the Intellectual Property Office
the Department for Exiting the European Union
Published 23 May 2018

Related

Life sciences credentialing register receives accreditation: a step forward for patient safety

Today, the Professional Standards Authority for Health and Social Care has approved the addition of ...

Read More >

The Medicines and Medical Devices Bill had its Second Reading yesterday evening. A common theme...

Read More >

The Government has announced two new members who will join the Coronavirus Test and Trace Programme ...

Read More >

NHS England has published its healthcare science strategy for England, outlining how to deliver the ...

Read More >

Revenues generated from IVD sales in the UK grew ahead of inflation in 2016, although positive growt...

Read More >

The UK IVD industry prepares for Brexit and new regulations.

Read More >